CN107137748A - 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 - Google Patents
一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 Download PDFInfo
- Publication number
- CN107137748A CN107137748A CN201710500522.1A CN201710500522A CN107137748A CN 107137748 A CN107137748 A CN 107137748A CN 201710500522 A CN201710500522 A CN 201710500522A CN 107137748 A CN107137748 A CN 107137748A
- Authority
- CN
- China
- Prior art keywords
- solution
- wound
- electrostatic spinning
- preparation
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010041 electrostatic spinning Methods 0.000 title claims abstract description 37
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 36
- 239000002121 nanofiber Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 239000000243 solution Substances 0.000 claims abstract description 50
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 18
- -1 polyoxyethylene Polymers 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000005909 Kieselgur Substances 0.000 claims abstract description 16
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims abstract description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000007864 aqueous solution Substances 0.000 claims abstract description 16
- 229910052744 lithium Inorganic materials 0.000 claims abstract description 16
- 238000009987 spinning Methods 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 12
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 9
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 9
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims abstract description 9
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims abstract description 9
- 239000011258 core-shell material Substances 0.000 claims abstract description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 5
- 229940048086 sodium pyrophosphate Drugs 0.000 claims abstract description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 6
- 238000013019 agitation Methods 0.000 claims 1
- 230000035876 healing Effects 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 5
- 239000011149 active material Substances 0.000 abstract description 4
- 230000023597 hemostasis Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000033115 angiogenesis Effects 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 208000027418 Wounds and injury Diseases 0.000 description 88
- 206010052428 Wound Diseases 0.000 description 85
- 230000000052 comparative effect Effects 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 9
- 230000029663 wound healing Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000835 fiber Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000446313 Lamella Species 0.000 description 2
- 206010051373 Wound haemorrhage Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- IPGANOYOHAODGA-UHFFFAOYSA-N dilithium;dimagnesium;dioxido(oxo)silane Chemical compound [Li+].[Li+].[Mg+2].[Mg+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O IPGANOYOHAODGA-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000004537 potential cytotoxicity Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/07—Stiffening bandages
- A61L15/08—Stiffening bandages containing inorganic materials, e.g. plaster of Paris
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/28—Formation of filaments, threads, or the like while mixing different spinning solutions or melts during the spinning operation; Spinnerette packs therefor
- D01D5/30—Conjugate filaments; Spinnerette packs therefor
- D01D5/34—Core-skin structure; Spinnerette packs therefor
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/02—Bandages, dressings or absorbent pads
- D10B2509/022—Wound dressings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Textile Engineering (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710500522.1A CN107137748B (zh) | 2017-06-27 | 2017-06-27 | 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710500522.1A CN107137748B (zh) | 2017-06-27 | 2017-06-27 | 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107137748A true CN107137748A (zh) | 2017-09-08 |
CN107137748B CN107137748B (zh) | 2020-05-26 |
Family
ID=59784416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710500522.1A Active CN107137748B (zh) | 2017-06-27 | 2017-06-27 | 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107137748B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108286082A (zh) * | 2018-03-08 | 2018-07-17 | 唐卫兵 | 一种高效防潮的多层醇酸树脂纳米纤维素纺丝液的制备方法 |
CN108998847A (zh) * | 2018-08-25 | 2018-12-14 | 诺斯贝尔化妆品股份有限公司 | 一种活性纳米包裹体静电纺丝纤维膜布的制备方法 |
CN111298184A (zh) * | 2020-04-20 | 2020-06-19 | 张丙起 | 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 |
CN114288458A (zh) * | 2021-12-06 | 2022-04-08 | 盐城工学院 | 一种免绷带固定的抗菌防粘连纳米纤维敷料及其制备方法 |
CN114960029A (zh) * | 2022-06-09 | 2022-08-30 | 中国地质大学(北京) | 一种介孔沸石多层止血纱布及其制备方法 |
CN115252869A (zh) * | 2022-08-18 | 2022-11-01 | 南通大学 | 一种促进血管再生的纳米敷料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103505758A (zh) * | 2013-09-17 | 2014-01-15 | 南通南京大学材料工程技术研究院 | 壳聚糖纳米纤维止血材料及其制备方法 |
CN103611182A (zh) * | 2013-12-10 | 2014-03-05 | 东华大学 | 一种医用敷料用核-壳结构超细纤维载体材料的制备方法 |
CN105199112A (zh) * | 2014-06-10 | 2015-12-30 | 天津工业大学 | 一种高强度γ-聚谷氨酸水凝胶的制备方法 |
-
2017
- 2017-06-27 CN CN201710500522.1A patent/CN107137748B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103505758A (zh) * | 2013-09-17 | 2014-01-15 | 南通南京大学材料工程技术研究院 | 壳聚糖纳米纤维止血材料及其制备方法 |
CN103611182A (zh) * | 2013-12-10 | 2014-03-05 | 东华大学 | 一种医用敷料用核-壳结构超细纤维载体材料的制备方法 |
CN105199112A (zh) * | 2014-06-10 | 2015-12-30 | 天津工业大学 | 一种高强度γ-聚谷氨酸水凝胶的制备方法 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108286082A (zh) * | 2018-03-08 | 2018-07-17 | 唐卫兵 | 一种高效防潮的多层醇酸树脂纳米纤维素纺丝液的制备方法 |
CN108998847A (zh) * | 2018-08-25 | 2018-12-14 | 诺斯贝尔化妆品股份有限公司 | 一种活性纳米包裹体静电纺丝纤维膜布的制备方法 |
CN111298184A (zh) * | 2020-04-20 | 2020-06-19 | 张丙起 | 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 |
CN111298184B (zh) * | 2020-04-20 | 2020-12-18 | 安徽迈德普斯医疗科技有限公司 | 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 |
CN114288458A (zh) * | 2021-12-06 | 2022-04-08 | 盐城工学院 | 一种免绷带固定的抗菌防粘连纳米纤维敷料及其制备方法 |
CN114288458B (zh) * | 2021-12-06 | 2023-03-14 | 盐城工学院 | 一种免绷带固定的抗菌防粘连纳米纤维敷料及其制备方法 |
CN114960029A (zh) * | 2022-06-09 | 2022-08-30 | 中国地质大学(北京) | 一种介孔沸石多层止血纱布及其制备方法 |
CN115252869A (zh) * | 2022-08-18 | 2022-11-01 | 南通大学 | 一种促进血管再生的纳米敷料及其制备方法 |
CN115252869B (zh) * | 2022-08-18 | 2023-06-06 | 南通大学 | 一种促进血管再生的纳米敷料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107137748B (zh) | 2020-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107137748A (zh) | 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 | |
Pilehvar-Soltanahmadi et al. | An overview on application of natural substances incorporated with electrospun nanofibrous scaffolds to development of innovative wound dressings | |
Joseph et al. | Recent advances in electrospun polycaprolactone based scaffolds for wound healing and skin bioengineering applications | |
Liu et al. | Recent development of electrospun wound dressing | |
Zhao et al. | Preparation of nanofibers with renewable polymers and their application in wound dressing | |
CN108324986B (zh) | 一种急性创伤用多功能有序释药医用敷膜及其制备方法 | |
CN103394114B (zh) | 一种医用敷料用壳聚糖基超细纤维载体材料的制备方法 | |
CN106267309B (zh) | 一种藻酸盐复合抗菌敷料及其制备方法 | |
CN107693835A (zh) | 一种聚乙烯醇/胶原蛋白/季铵化壳聚糖静电纺丝复合纤维膜及其制备方法 | |
CN106390177A (zh) | 一种壳聚糖基多层纳米纤维膜敷料及其制备方法和应用 | |
CN102908653A (zh) | 一种用于深度感染性伤口的抗菌敷料制备方法 | |
CN105664225A (zh) | 一种纳米银、壳聚糖和蚕丝蛋白复合生物敷料及其制备方法 | |
Ilomuanya et al. | Development and characterization of collagen-based electrospun scaffolds containing silver sulphadiazine and Aspalathus linearis extract for potential wound healing applications | |
CN109731121A (zh) | 一种含有介孔二氧化硅的纤维素和壳聚糖复合敷料的制备方法 | |
Sabarees et al. | Emerging trends in silk fibroin based nanofibers for impaired wound healing | |
CN106110383A (zh) | 一种壳聚糖藻酸盐敷料及其冻干制备方法 | |
CN104623718A (zh) | 壳聚糖凡士林纱布及其制备方法 | |
Chang et al. | 3D PCL/collagen nanofibrous medical dressing for one-time treatment of diabetic foot ulcers | |
CN107432951A (zh) | 一种负载四氢姜黄素纳米颗粒的海藻酸钠‑壳聚糖敷料及其制备方法 | |
CN107261200A (zh) | 一种壳聚糖‑纳米锂藻土复合凝胶伤口敷料及其制备方法 | |
Zhang et al. | Nanocellulose aerogels from banana pseudo-stem as a wound dressing | |
CN103436992B (zh) | 一种负载纳米载药胶囊的海藻纤维的制备方法 | |
CN1775302A (zh) | 壳聚糖-明胶海绵伤口敷料的制备方法 | |
CN102921035A (zh) | 一种用于深度感染性伤口的抗菌敷料 | |
CN106860906A (zh) | 一种抗菌纳米纤维伤口敷料的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240202 Address after: 430000, Room 508, 5th Floor, Building 7, West Zhongchuang Health Industry Park (Phase I), Huashan Wu Village, Miaoshan Office, Jiangxia District, Wuhan City, Hubei Province, China Patentee after: Aiyisheng (Hubei) Medical Technology Co.,Ltd. Country or region after: China Address before: 434000 Wangjiagang Road, Jingzhou Development Zone, Jingzhou City, Hubei Province, 1-3 blocks Patentee before: HUBEI CNCUN MEDICINE CO.,LTD. Country or region before: China |